Institutional Ownership
Whitehawk Therapeutics Inc
CUSIP 00032Q104COMWHWKQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
59
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Aug 25, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 25, 2025 | Coastlands Capital LP | 13G | 6.0% | 2.82M | SEC |
| 2 | May 15, 2025 | Orbimed Advisors LLC | 13G | 8.9% | 41.66T | SEC |
| 3 | May 15, 2025 | Point72 Asset Management, L.P. | 13G/A | — | 5.1K | SEC |
| 4 | Mar 11, 2025 | Suvretta Capital Management, LLC | 13G | 10.0% | 4.73M | SEC |
| 5 | Mar 10, 2025 | Abg Management Ltd. | 13G | 6.3% | 2.91M | SEC |
| 6 | Mar 6, 2025 | Neil Desai | 13D/A | 4.9% | — | SEC |
| 7 | Mar 5, 2025 | Bml Investment Partners, L.P. | 13D/A | 5.0% | — | SEC |
| 8 | Mar 4, 2025 | Avoro Capital Advisors LLC | 13D/A | 20.0% | — | SEC |
| 9 | Feb 24, 2025 | Bml Investment Partners, L.P. | 13D/A | 9.9% | — | SEC |
| 10 | Feb 14, 2025 | Qvt Financial LP | 13G | 9.4% | 2.31M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Whitehawk Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Qvt Financial LP | 4.62M | $15.92M |
| 2 | Orbimed Advisors LLC | 4.17M | $14.37M |
| 3 | Suvretta Capital Management, LLC | 3.70M | $12.77M |
| 4 | Acuta Capital Partners, LLC | 3.41M | $11.77M |
| 5 | Avoro Capital Advisors LLC | 2.85M | $9.83M |
| 6 | Kvp Capital Advisors, LP | 2.17M | $7.47M |
| 7 | Siren, L.L.C. | 2.08M | $7.18M |
| 8 | Yu Fan | 2.07M | $7.14M |
| 9 | Acorn Capital Advisors, LLC | 1.14M | $3.93M |
| 10 | Stempoint Capital LP | 939.4K | $3.24M |